S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   416.75 (-1.57%)
AAPL   165.04 (-1.20%)
MSFT   400.12 (-1.03%)
META   484.70 (-3.41%)
GOOGL   154.17 (-1.18%)
AMZN   174.99 (-2.36%)
TSLA   149.15 (-0.52%)
NVDA   804.98 (-4.93%)
AMD   149.23 (-3.77%)
NIO   3.84 (-4.00%)
BABA   68.92 (+0.06%)
T   16.40 (+0.43%)
F   12.11 (+0.41%)
MU   106.72 (-4.65%)
GE   149.39 (-2.32%)
CGC   8.17 (+4.34%)
DIS   112.17 (-0.23%)
AMC   3.26 (+11.64%)
PFE   25.80 (+1.61%)
PYPL   62.14 (+0.06%)
XOM   119.98 (+1.23%)
S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   416.75 (-1.57%)
AAPL   165.04 (-1.20%)
MSFT   400.12 (-1.03%)
META   484.70 (-3.41%)
GOOGL   154.17 (-1.18%)
AMZN   174.99 (-2.36%)
TSLA   149.15 (-0.52%)
NVDA   804.98 (-4.93%)
AMD   149.23 (-3.77%)
NIO   3.84 (-4.00%)
BABA   68.92 (+0.06%)
T   16.40 (+0.43%)
F   12.11 (+0.41%)
MU   106.72 (-4.65%)
GE   149.39 (-2.32%)
CGC   8.17 (+4.34%)
DIS   112.17 (-0.23%)
AMC   3.26 (+11.64%)
PFE   25.80 (+1.61%)
PYPL   62.14 (+0.06%)
XOM   119.98 (+1.23%)
S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   416.75 (-1.57%)
AAPL   165.04 (-1.20%)
MSFT   400.12 (-1.03%)
META   484.70 (-3.41%)
GOOGL   154.17 (-1.18%)
AMZN   174.99 (-2.36%)
TSLA   149.15 (-0.52%)
NVDA   804.98 (-4.93%)
AMD   149.23 (-3.77%)
NIO   3.84 (-4.00%)
BABA   68.92 (+0.06%)
T   16.40 (+0.43%)
F   12.11 (+0.41%)
MU   106.72 (-4.65%)
GE   149.39 (-2.32%)
CGC   8.17 (+4.34%)
DIS   112.17 (-0.23%)
AMC   3.26 (+11.64%)
PFE   25.80 (+1.61%)
PYPL   62.14 (+0.06%)
XOM   119.98 (+1.23%)
S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   416.75 (-1.57%)
AAPL   165.04 (-1.20%)
MSFT   400.12 (-1.03%)
META   484.70 (-3.41%)
GOOGL   154.17 (-1.18%)
AMZN   174.99 (-2.36%)
TSLA   149.15 (-0.52%)
NVDA   804.98 (-4.93%)
AMD   149.23 (-3.77%)
NIO   3.84 (-4.00%)
BABA   68.92 (+0.06%)
T   16.40 (+0.43%)
F   12.11 (+0.41%)
MU   106.72 (-4.65%)
GE   149.39 (-2.32%)
CGC   8.17 (+4.34%)
DIS   112.17 (-0.23%)
AMC   3.26 (+11.64%)
PFE   25.80 (+1.61%)
PYPL   62.14 (+0.06%)
XOM   119.98 (+1.23%)
NYSE:HRT

HireRight (HRT) Stock Price, News & Analysis

$14.25
0.00 (0.00%)
(As of 01:43 PM ET)
Today's Range
$14.23
$14.28
50-Day Range
$12.55
$14.34
52-Week Range
$8.50
$14.38
Volume
164,125 shs
Average Volume
480,327 shs
Market Capitalization
$40.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.50

HireRight MarketRank™ Stock Analysis

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
12.3% Downside
$12.50 Price Target
Short Interest
Healthy
1.83% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.08mentions of HireRight in the last 14 days
Based on 15 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.30 out of 5 stars

Industrials Sector

11th out of 13 stocks

Staffing & Employment Services Industry

2nd out of 2 stocks

HRT stock logo

About HireRight Stock (NYSE:HRT)

HireRight Holdings Corporation provides technology-driven workforce risk management and compliance solutions worldwide. It offers background screening, verification, identification, monitoring, and drug and health screening services for customers under the HireRight brand name. The company provides its services through software and data platform that integrates into its customers' human capital management systems enabling workflows for workforce hiring, onboarding, and monitoring. It serves transportation, healthcare, technology, financial services, business and consumer services, manufacturing, education, and retail industries, as well as not-for-profit organizations. HireRight Holdings Corporation was incorporated in 1990 and is headquartered in Nashville, Tennessee.

HRT Stock Price History

HRT Stock News Headlines

HireRight (NYSE:HRT) Research Coverage Started at StockNews.com
Biden replacement revealed?
A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.
Your Next Portfolio Star: Revealing 2024's Top Stock Pick
We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)
HireRight (NYSE:HRT) Now Covered by StockNews.com
See More Headlines
Receive HRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HireRight and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/12/2024
Today
4/19/2024

Industry, Sector and Symbol

Industry
Staffing & Employment Services
Sub-Industry
N/A
Fax
N/A
Employees
3,190
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.50
High Stock Price Target
$15.00
Low Stock Price Target
$11.00
Potential Upside/Downside
-12.3%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$721.88 million

Miscellaneous

Free Float
N/A
Market Cap
$40.19 million
Optionable
Not Optionable
Beta
0.17
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Guy P. Abramo (Age 62)
    CEO, President & Director
    Comp: $1.35M
  • Mr. Thomas M. Spaeth (Age 56)
    CFO & Treasurer
    Comp: $800.7k
  • Mike Ensor
    Senior VP & Global Head of Operations
  • Ms. Laurie J. Blanton (Age 70)
    Senior VP & Chief Accounting Officer
  • Mr. Jeffery T. Mullins
    Chief Technology Officer
  • Mr. Brian W. Copple (Age 63)
    General Counsel & Secretary
  • Ms. Ann Losiewski
    Head of Global Sales
  • Ms. Julie Romero (Age 49)
    Chief Human Resources Officer
  • Mr. Stephen R. Girdler (Age 61)
    Advisor
  • Mr. Jim Daxner
    Executive VP & Global Head of Product

HRT Stock Analysis - Frequently Asked Questions

Should I buy or sell HireRight stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for HireRight in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HRT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HRT, but not buy additional shares or sell existing shares.
View HRT analyst ratings
or view top-rated stocks.

What is HireRight's stock price target for 2024?

5 Wall Street research analysts have issued 12 month price objectives for HireRight's stock. Their HRT share price targets range from $11.00 to $15.00. On average, they predict the company's share price to reach $12.50 in the next twelve months. This suggests that the stock has a possible downside of 12.3%.
View analysts price targets for HRT
or view top-rated stocks among Wall Street analysts.

How have HRT shares performed in 2024?

HireRight's stock was trading at $13.45 at the beginning of the year. Since then, HRT shares have increased by 6.0% and is now trading at $14.26.
View the best growth stocks for 2024 here
.

Are investors shorting HireRight?

HireRight saw a drop in short interest in March. As of March 31st, there was short interest totaling 299,600 shares, a drop of 22.3% from the March 15th total of 385,500 shares. Based on an average daily trading volume, of 502,000 shares, the short-interest ratio is currently 0.6 days. Approximately 1.8% of the company's stock are short sold.
View HireRight's Short Interest
.

How were HireRight's earnings last quarter?

HireRight Holdings Co. (NYSE:HRT) announced its quarterly earnings results on Tuesday, March, 12th. The company reported $0.16 EPS for the quarter, beating the consensus estimate of $0.13 by $0.03. The firm had revenue of $166.04 million for the quarter, compared to the consensus estimate of $170.35 million.

Is HireRight a good dividend stock?

HireRight (NYSE:HRT) pays an annual dividend of $0.12 per share and currently has a dividend yield of 0.00%.

What ETF holds HireRight's stock?

AltShares Merger Arbitrage ETF holds 58,010 shares of HRT stock, representing 1.35% of its portfolio.

When did HireRight IPO?

HireRight (HRT) raised $500 million in an IPO on Friday, October 29th 2021. The company issued 22,222,222 shares at $21.00-$24.00 per share.

How do I buy shares of HireRight?

Shares of HRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:HRT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners